Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1948]
News [3633]
Articles [95]
Editorials [5]
Conferences [157]
elearning [19]
Mutations associated with sensitivity or resistance to immunotherapy in mNSCLC
Mutations associated with sensitivity or resistance to immunotherapy in mNSCLC
Protein mapping pinpoints why metastatic melanoma patients do not respond to immunotherapy
Protein mapping pinpoints why metastatic melanoma patients do not respond to immunotherapy
Final trial results from new NSCLC immunotherapy
Final trial results from new NSCLC immunotherapy
Survival update on new first-line therapy for advanced NSCLC
Survival update on new first-line therapy for advanced NSCLC
Preclinical study reveals the impact of age on immunotherapy treatment for breast cancer
Preclinical study reveals the impact of age on immunotherapy treatment for breast cancer
Nivolumab combined with ipilimumab safe as first-line therapy for lung cancer patients
Nivolumab combined with ipilimumab safe as first-line therapy for lung cancer patients
New KEYNOTE 021 data shows no association with tumour mutational burden
New KEYNOTE 021 data shows no association with tumour mutational burden
New study reinforces clinical utility of combining TMB and PD-L1 as predictive biomarkers for immune checkpoint inhibitor therapy
New study reinforces clinical utility of combining TMB and PD-L1 as predictive biomarkers for immune checkpoint...
Delivering immunotherapy directly to brain tumours
Delivering immunotherapy directly to brain tumours
Turbocharging the body's natural killer cells to defeat cancer
Turbocharging the body's natural killer cells to defeat cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation